Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

January 19, 2022

MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer.

Oncogene
A CannistraciR Marais
January 19, 2022

Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review).

Oncology Reports
Na ChenJin-Bai Huang
January 19, 2022

Circ_0000467 Exerts an Oncogenic Role in Colorectal Cancer via miR-330-5p-Dependent Regulation of TYRO3.

Biochemical Genetics
Yubao HuangHai Huang
January 18, 2022
Preprint
Open Access

The secreted metabolome of HeLa cells under effect of Crotamine, a cell-penetrating peptide from a rattlesnake using NMR-based metabolomics analyses

BioRxiv : the Preprint Server for Biology
Monika A. CoronadoR. K. Arni
January 17, 2022

Regulation of gene expression in the development of colitis-associated colon cancer in mice fed a high-fat diet.

Biochemical and Biophysical Research Communications
Young Woo Cho, Young Hye Kwon
January 17, 2022
Open Access

Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover.

Cancer & Metabolism
Nikki L RaftopulosAndrew J Hoy
January 16, 2022

Plasma metabolomic profiles for colorectal cancer precursors in women.

European Journal of Epidemiology
Dong HangMingyang Song
January 16, 2022
Review

Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Molecular Biology Reports
Cui WuBingmei Wang
January 16, 2022

Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Francesco NicoliVictor Appay
January 16, 2022

Low glucose-induced overexpression of HOXC-AS3 promotes metabolic reprogramming of breast cancer.

Cancer Research
Wen-Jie ZhuPeng Gao
January 16, 2022
Review

Ubiquitination regulation of aerobic glycolysis in cancer.

Life Sciences
Yao XieJing Zhong

Sign up to follow this feed and discover related papers.

Related Feeds

Adipose Tissue Heterogeneity

Examining the genomics, transcriptomics, proteomics, and metabolomics of adipose tissue at the single cell level will help build a single cell atlas of these tissues, providing insights into how changes in the map underlie health and disease states. Discover the latest research on adipose tissue heterogeneity here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

© 2022 Meta ULC. All rights reserved
/feed-previews/cancer-metabolic-reprogramming/cfdc46a9-4e8a-4bb0-a0bd-ddf65173a8f4